Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Rodriguez

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Plos One|January 30, 2013
Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patientsPablo Martinez, Javier Hernández-Losa, Ma Ángeles Montero, et al.
British Journal of Anaesthesia|June 4, 2021
Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgeryKe Peng, Yue-Ping Shen, Yao-Yu Ying, et al.
Cancers|October 30, 2020
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II StudyUlrich-Frank Pape, Stefan Kasper, Johannes Meiler, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Deconvoluting Kinase Inhibitor Induced CardiotoxicitySarah D Lamore, Ernst Ahlberg, Scott Boyer, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2018
TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6Clara Franco-Jarava, Hongying Wang, Andrea Martin-Nalda, et al.
Stroke|December 17, 2013
Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysisVíctor Llombart, Carmen Dominguez, Alejandro Bustamante, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Future Science OA|June 6, 2022
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot studyMaría Angeles Vaz Salgado, Julie Earl, Victor Rodriguez Berrocal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2023
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Plos One|January 30, 2013
Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patientsPablo Martinez, Javier Hernández-Losa, Ma Ángeles Montero, et al.
British Journal of Anaesthesia|June 4, 2021
Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgeryKe Peng, Yue-Ping Shen, Yao-Yu Ying, et al.
Cancers|October 30, 2020
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II StudyUlrich-Frank Pape, Stefan Kasper, Johannes Meiler, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Deconvoluting Kinase Inhibitor Induced CardiotoxicitySarah D Lamore, Ernst Ahlberg, Scott Boyer, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2018
TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6Clara Franco-Jarava, Hongying Wang, Andrea Martin-Nalda, et al.
Stroke|December 17, 2013
Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysisVíctor Llombart, Carmen Dominguez, Alejandro Bustamante, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Future Science OA|June 6, 2022
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot studyMaría Angeles Vaz Salgado, Julie Earl, Victor Rodriguez Berrocal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2023
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, et al.
Pageof 11